Pharma Journalist - Page 46 of 946 -

Aurisco Passes FDA Inspection for Generic Oligonucleotide APIs

Alfasigma to Acquire Nordic Pharma in Global Expansion

Lilly Files Six Lawsuits Against Black-Market Retatrutide Sellers

Synaffix and Sidewinder Partner to Develop Next-Generation Bispecific ADCs

FDA Grants Fast Track to Alessa’s Localized Prostate Cancer Therapy

FDA Grants Orphan Status to Cellenkos’ CK0804 in Myelofibrosis

Santhera Licenses AGAMREE to Nxera in Key Asia-Pacific Markets

Lilly Trial Shows Dual Therapy Benefits in Psoriatic Arthritis Patients

Amgen Acquires Dark Blue to Advance Novel AML Treatments

FDA Approves New 2-Gram Fibryga Kit for Bleeding Care

GSK Phase III Trials Show Promise for Chronic Hepatitis B Therapy

Takeda Expands Entyvio Options Through Halozyme Technology Partnership

Lilly to Acquire Ventyx in $1.2 Billion Inflammation Deal